Header cover image

French (CAC) Clinical Research and Equipment Industry Analysis

UpdatedDec 19, 2024
DataAggregated Company Financials
Companies3
  • 7D-1.7%
  • 3M-2.2%
  • 1Y-21.6%
  • YTDn/a

The Clinical Research and Equipment industry is up 2.7% in the last week, with Eurofins-Cerep up 11%. In contrast, the industry has lost 17% in the last 12 months. Looking forward, earnings are forecast to grow by 27% annually.

Industry Valuation and Performance

Has the French Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 19 Dec 2024€27.4b€9.5b€494.1m27.7x55.5x2.9x
Sat, 16 Nov 2024€25.4b€9.5b€494.1m26.4x51.3x2.7x
Mon, 14 Oct 2024€29.0b€9.5b€503.0m32.4x57.6x3x
Wed, 11 Sep 2024€28.6b€9.5b€503.0m31.1x56.9x3x
Fri, 09 Aug 2024€27.3b€9.5b€503.0m31.2x54.4x2.9x
Sun, 07 Jul 2024€24.8b€9.3b€518.8m36x47.8x2.7x
Tue, 04 Jun 2024€28.5b€9.3b€518.8m41.9x55x3.1x
Thu, 02 May 2024€31.0b€9.3b€522.7m43.3x59.3x3.3x
Sat, 30 Mar 2024€37.2b€9.3b€577.7m44.3x64.4x4x
Mon, 26 Feb 2024€35.7b€9.3b€735.1m26.9x48.6x3.8x
Wed, 24 Jan 2024€31.4b€9.5b€885.8m25.9x35.4x3.3x
Fri, 22 Dec 2023€33.8b€9.5b€885.8m27.4x38.2x3.6x
Sun, 19 Nov 2023€28.7b€9.5b€885.8m24.5x32.4x3x
Tue, 17 Oct 2023€27.2b€9.7b€1.1b23.5x25.7x2.8x
Thu, 14 Sep 2023€33.5b€9.7b€1.1b25.3x31.5x3.4x
Sat, 12 Aug 2023€35.7b€9.7b€1.1b26.8x33.7x3.7x
Mon, 10 Jul 2023€31.7b€10.1b€1.3b18.8x24.2x3.1x
Wed, 07 Jun 2023€37.1b€10.1b€1.3b20.6x28.4x3.7x
Fri, 05 May 2023€35.9b€10.1b€1.3b21.2x27.4x3.5x
Sun, 02 Apr 2023€38.0b€10.3b€1.5b20.5x25.9x3.7x
Tue, 28 Feb 2023€42.9b€10.4b€1.5b20.6x28x4.1x
Thu, 26 Jan 2023€40.5b€10.3b€1.3b19x30.4x3.9x
Sat, 24 Dec 2022€40.6b€10.3b€1.3b19.8x30.5x4x
Mon, 21 Nov 2022€43.6b€10.5b€1.3b19.8x33.7x4.2x
Wed, 19 Oct 2022€44.3b€10.3b€1.2b18.7x35.8x4.3x
Fri, 16 Sep 2022€47.0b€10.3b€1.2b20.2x38x4.5x
Sun, 14 Aug 2022€49.9b€10.3b€1.2b22.6x40.3x4.8x
Tue, 12 Jul 2022€46.8b€10.0b€1.3b20x36.8x4.7x
Thu, 09 Jun 2022€46.2b€10.0b€1.3b22x36.3x4.6x
Sat, 07 May 2022€43.8b€10.0b€1.3b21.7x34.3x4.4x
Mon, 04 Apr 2022€52.7b€9.8b€1.1b23.4x46.7x5.4x
Wed, 02 Mar 2022€49.3b€9.8b€1.1b23.2x43.7x5x
Fri, 28 Jan 2022€50.7b€9.3b€1.3b20.2x37.8x5.5x
Sun, 26 Dec 2021€64.2b€9.3b€1.3b25.3x47.9x6.9x
Price to Earnings Ratio

47.9x


Total Market Cap: €64.2bTotal Earnings: €1.3bTotal Revenue: €9.3bTotal Market Cap vs Earnings and Revenue0%0%0%
French Clinical Research and Equipment Industry Price to Earnings3Y Average 40.1x202220232024
Current Industry PE
    There are only 3 companies in the French Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have declined 28% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does French Clinical Research and Equipment compare with similar industries?

FR Market-0.59%
Healthcare0.59%
Life Sciences-1.71%
Clinical Research and Equipment-1.71%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.